No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Bethkis (Tobramycin Inhalation Solution) is a respiratory drug used to treat cystic fibrosis (CF). It is an inhaled antibiotic that helps to reduce the amount of bacteria in the lungs of CF patients. It is administered through a nebulizer, which is a device that turns liquid medication into a mist that can be inhaled. Bethkis is the only inhaled antibiotic approved by the U.S. Food and Drug Administration (FDA) for the treatment of CF.
Bethkis is manufactured by Chiesi USA, Inc., a subsidiary of Chiesi Farmaceutici S.p.A., an Italian pharmaceutical company. Other companies in the respiratory drug market include GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies produce a variety of drugs for the treatment of respiratory diseases, including bronchodilators, anti-inflammatory drugs, and antibiotics. Show Less Read more
